MCID: STR008
MIFTS: 50

Strongyloidiasis malady

Categories: Rare diseases, Infectious diseases, Gastrointestinal diseases

Aliases & Classifications for Strongyloidiasis

About this section
Sources:
2CDC, 11Disease Ontology, 13DISEASES, 30ICD10, 31ICD10 via Orphanet, 32ICD9CM, 39MeSH, 40MESH via Orphanet, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Strongyloidiasis:

Name: Strongyloidiasis 11 48 54 50 2 39 13 68
Disseminated Strongyloidiasis 11 68
Anguilluliasis 54 68
Infection by Strongyloides 11
 
Threadworm Infection 48
Anguillulosis 54
Enterobiasis 68

Characteristics:

Orphanet epidemiological data:

54
strongyloidiasis:
Inheritance: Not applicable; Age of onset: All ages

Classifications:



External Ids:

Disease Ontology11 DOID:10955
ICD1030 B78, B78.9, B78.7
ICD9CM32 127.2
MeSH39 D013322
Orphanet54 ORPHA76
MESH via Orphanet40 D013322
ICD10 via Orphanet31 B78.0, B78.9, B78.1 B78.7, more
UMLS via Orphanet69 C0038463

Summaries for Strongyloidiasis

About this section
NIH Rare Diseases:48 Strongyloidiasis is a parasitic disease caused by the roundworm Strongyloides stercoralis (S. stercoralis). People catch the infection when they come in contact with soil contaminated with the worms. While there are often no symptoms, abdominal pain, cough, diarrhea, rash, unintentional weight loss and vomiting may occur. The infection is treated with anti-worm medications such as ivermectin. Strongyloidiasis is found in tropical and subtropical areas, but can also be found in temperate regions, including the southern United States. Last updated: 9/20/2010

MalaCards based summary: Strongyloidiasis, also known as disseminated strongyloidiasis, is related to asthma and gastroschisis abdominal wall defects, included, and has symptoms including pruritus An important gene associated with Strongyloidiasis is IL5 (Interleukin 5), and among its related pathways are Inflammatory Response Pathway and Malaria. The drugs ivermectin and thiabendazole have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and lung, and related mouse phenotypes are neoplasm and hematopoietic system.

Disease Ontology:11 A parasitic helminthiasis infectious disease that involves infection of the intestine, lungs, skin and central nervous system with nematode Strongyloides stercoralis.

CDC:2 Strongyloidiasis was first described in French troops stationed in modern day Vietnam during the late 19th century who were suffering from severe, persistent diarrhea. It is a parasitic disease caused by nematodes, or roundworms, in the genus Strongyloides that enter the body through exposed skin, such as bare feet. Strongyloides is most common in tropical or subtropical climates.

Wikipedia:71 Strongyloidiasis is a human parasitic disease caused by the nematode (roundworm) called Strongyloides... more...

Related Diseases for Strongyloidiasis

About this section

Diseases related to Strongyloidiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 205)
idRelated DiseaseScoreTop Affiliating Genes
1asthma27.7CCL11, CD79A, IFNG, IL13, IL5, TGFB1
2gastroschisis abdominal wall defects, included10.5IFNG, IL5
3thomsen and becker disease10.5IFNG, IL5
4gonococcal synovitis10.5IFNG, IL5
5autism spectrum disorder10.5CD79A, IL5
6endometrial stromal nodule10.5CD79A, IFNG
7opiate dependence10.4IFNG, IL5
8philophthalmiasis10.4CD79A, IL5
9chronic hiccups10.4CD79A, IFNG
10vaginal squamous tumor10.4CD79A, IL5
11lymphocytic colitis10.4CD79A, IFNG
12idiopathic neutropenia10.4IFNG, IL5
13primary orthostatic tremor10.4CD79A, IFNG
14multiple system atrophy, cerebellar type10.4IFNG, IL5
15proliferative glomerulonephritis10.4CD79A, TGFB1
16pneumonic tularemia10.4CD79A, IFNG
17giant ganglionic hyperplasia10.4CCL11, IL5
18renal hypertension10.4CD79A, TGFB1
19keratopathy10.4IFNG, TGFB1
20solitary cyst of breast10.4CCL11, IL5
21bolivian hemorrhagic fever10.4CD79A, IFNG
22fungal gastritis10.4CCL11, IL5
23malignant histiocytosis10.4CD79A, IFNG
24benign mammary dysplasia10.4CCL11, IL5
25bartonellosis10.4CD79A, IFNG
26lacrimal system cancer10.3CD79A, IFNG
27pituitary hypoplasia10.3CCL11, IL5
28tinea barbae10.3CD79A, IFNG
29calcifying epithelial odontogenic tumor10.3IFNG, TGFB1
30intrinsic cardiomyopathy10.3CD79A, IFNG
31orbital lymphangioma10.3IFNG, TGFB1
32hyperostosis frontalis interna10.3CD79A, TGFB1
33small intestine leiomyoma10.3CCL11, CD79A
34chronic conjunctivitis10.3CD79A, IFNG
35cytoplasmic body myopathy10.3IL13, IL5
36wissler's syndrome10.3IFNG, IL5
37aortic arch interruption10.3IL13, IL5
38toxic diffuse goiter10.3IL13, IL5
39papillary squamous carcinoma10.3IL13, IL5
40cherry allergy10.3IL13, IL5
41binocular vision disease10.3IFNG, TGFB1
42glucose intolerance10.3IL13, IL5
43skin disease10.3IL13, IL5
44purpura fulminans10.3IL13, IL5
45heart leiomyosarcoma10.3CD79A, IFNG
46gastric ulcer10.3IFNG, IL5
47epidermolysis bullosa simplex superficialis10.3CD79A, TGFB1
48juvenile dermatitis herpetiformis10.3CCL11, CD79A
49louping ill10.3IFNG, TGFB1
50urinary bladder small cell neuroendocrine carcinoma10.2IL13, IL5

Graphical network of the top 20 diseases related to Strongyloidiasis:



Diseases related to strongyloidiasis

Symptoms & Phenotypes for Strongyloidiasis

About this section

UMLS symptoms related to Strongyloidiasis:


pruritus

MGI Mouse Phenotypes related to Strongyloidiasis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020069.6CD79A, IFNG, IL5, TGFB1
2MP:00053978.5CCL11, CD79A, IFNG, IL13, IL5, TGFB1
3MP:00053878.5CCL11, CD79A, IFNG, IL13, IL5, TGFB1
4MP:00053888.1CCL11, IFNG, IL13, IL5, TGFB1

Drugs & Therapeutics for Strongyloidiasis

About this section

Drugs for Strongyloidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Albendazoleapproved, vet_approvedPhase 38054965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
2
Ivermectinapproved, vet_approvedPhase 35770288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
 
HMS2089M09
I 8898
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
3AnthelminticsPhase 3431
4Anti-Infective AgentsPhase 321402
5Antiprotozoal AgentsPhase 31986
6Antiparasitic AgentsPhase 32127
7Antimitotic AgentsPhase 35498
8
Formaldehydeapproved, vet_approved8450-00-0712
Synonyms:
Aldeide formica
Fannoform
Formaldehyde
Formalin
Formalina
Formaline
Formalith
Formic aldehyde
Formol
 
Methaldehyde
Methanal
Methyl aldehyde
Methylene glycol
Methylene oxide
Oxomethane
Oxomethylene
Oxymethylene
Paraform
Paraformaldehyde
9
Mebendazoleapproved, vet_approved2431431-39-74030
Synonyms:
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Benzoyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI)
31431-39-7
46404_FLUKA
46404_RIEDEL
5-Benzoyl-2-benzimidazolecarbamic acid methyl ester
5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester
AB00052203
AC-12064
AC1L1H98
AC1Q44DR
AKOS000539066
Abello Farmacia Brand of Mebendazole
Anti Worm
Anti-Worm
Ardeypharm Brand of Mebendazole
BAS 00341140
BIDD:GT0087
BPBio1_000257
BRD-K77987382-001-01-7
BRD-K77987382-001-06-6
BSPBio_000233
BSPBio_003178
Bantenol
Banworm
Besantin
Bio-0458
Bio-0803
Boots Brand of Mebendazole
Boots Threadworm Treatment
CAS-31431-39-7
CBDivE_010559
CCRIS 4479
CHEBI:6704
CHEMBL685
CID4030
CPD000036734
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI)
Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester
D00368
D008463
DB00643
Degort's Brand of Mebendazole
Diba Brand of Mebendazole
DivK1c_000751
EINECS 250-635-4
Elfar Brand of Mebendazole
Equivurm Plus
Esteve Brand of Mebendazole
HMS1536H11
HMS1568L15
HMS1921F03
HMS2090B03
HMS2092B15
HMS502F13
HSDB 3232
Healthypharm Brand of Mebendazole
I06-2075
IDI1_000751
Janssen Brand of Mebendazole
KBio1_000751
KBio2_001778
KBio2_004346
KBio2_006914
KBio3_002398
KBioGR_000712
KBioSS_001778
LS-48951
Leidapharm Brand of Mebendazole
Lomper
M2523_FLUKA
M2523_SIGMA
MBDZ
MEBENDAZOLE, 99%
MLS000028491
Madicure
Mebendan
Mebendazol
Mebendazol [INN-Spanish]
Mebendazole (JAN/USP)
 
Mebendazole (JAN/USP/INN)
Mebendazole [USAN:INN:BAN:JAN]
Mebendazole(USAN)
Mebendazolum
Mebendazolum [INN-Latin]
Mebenoazole
Mebenvet
Mebex
Mebutar
Methyl 5-benzoyl benzimidazole-2-carbamate
Methyl 5-benzoyl-2-benzimidazolecarbamate
Methyl 5-benzoyl-2-benzimidazolylcarbamate
Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate
Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate
MolPort-000-765-625
MolPort-001-889-615
Mébendazole
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French]
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French]
NCGC00016806-01
NCGC00016806-02
NCGC00021698-03
NCGC00021698-04
NCGC00021698-05
NCGC00021698-06
NINDS_000751
NSC 184849
NSC184849
Norgine Brand of Mebendazole
Noverme
Oprea1_278237
Oprea1_768530
Ovitelmin
Pantelmin
Pfizer Brand of Mebendazole
Prestwick0_000217
Prestwick1_000217
Prestwick2_000217
Prestwick3_000217
Prestwick_310
Pripsen Mebendazole
Probes1_000013
Probes2_000149
R 17,635
R 17635
R-17635
R17635
SAM002548959
SMR000036734
SPBio_001442
SPBio_002154
SPECTRUM1501110
SSL Brand of Mebendazole
STK093862
Spectrum2_001401
Spectrum3_001439
Spectrum4_000416
Spectrum5_001381
Spectrum_001298
Sqworm
Streger Brand of Mebendazole
Sufil
Surfont
TL8002405
Taxandria Brand of Mebendazole
Tedec Meiji Brand of Mebendazole
Telmin
TimTec1_000869
UNII-81G6I5V05I
Vermicidin
Vermicol
Vermidil
Vermin
Vermirax
Vermox
Vermox (TN)
Verpanyl
Versid
Wormkuur
ZINC00121541
mebendazole
methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate
10
Piperazineapproved, vet_approved24110-85-04837
Synonyms:
1,4-Diazacyclohexane
1,4-Diethylenediamine
1,4-Piperazine
110-85-0
14007-05-7 (unspecified hydrobromide)
142-63-2 (hexahydrate)
142-64-3 (di-hydrochloride)
14538-56-8 (phosphate[1:1])
16832-43-2 (unspecified hydrate)
1951-97-9 (unspecified phosphate)
3597-26-0 (unspecified sulfate)
5-23-01-00030 (Beilstein Handbook Reference)
6094-40-2 (unspecified hydrochloride)
7542-23-6 (mono-hydrochloride)
8017-90-1
8027-81-4
8057-14-5 (unspecified salt)
80621_FLUKA
854880-15-2
861800-35-3
AB1003720
AC1L1J2E
AC1Q1IA7
AC1Q1IA8
AC1Q1IA9
AKOS000269028
AR-1L1009
ARONIS23910
Anthalazine
Antiren
Asca-Trol No. 3
BIDD:GT0273
BRN 0102555
C07973
CCRIS 5950
CHEBI:28568
CHEMBL1412
CID4837
D00807
DB00592
Diethylenediamine
Diethyleneimine
Dispermine
DivK1c_000038
EINECS 203-808-3
Eraverm
Eraverm (VAN)
Fluphenazine dihydrochloride
HMS1920H20
HMS2092A03
HMS500B20
HSDB 1093
Hexahydro-1,4-diazine
Hexahydropyrazine
I14-11172
IDI1_000038
InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H
Jsp000824
KBio1_000038
KBio2_001593
KBio2_004161
KBio2_006729
KBioSS_001593
LS-517
LTBB000432
Lumbrical
MolPort-000-872-010
NCGC00094762-01
NCGC00094762-02
NCIOpen2_000984
NCIOpen2_000988
NCIOpen2_001024
NCIOpen2_001031
NCIOpen2_001033
NCIOpen2_001071
 
NCIOpen2_001073
NCIOpen2_001111
NCIOpen2_001151
NCIOpen2_001231
NCIOpen2_001262
NCIOpen2_001269
NCIOpen2_004830
NCIOpen2_004834
NCIOpen2_004862
NCIOpen2_004874
NCIOpen2_004904
NCIOpen2_004910
NCIOpen2_004914
NCIOpen2_004942
NCIOpen2_004952
NCIOpen2_004954
NCIOpen2_004982
NCIOpen2_004992
NCIOpen2_004994
NCIOpen2_005022
NCIOpen2_005032
NCIOpen2_005034
NCIOpen2_005062
NCIOpen2_005072
NCIOpen2_005102
NCIOpen2_005108
NCIOpen2_005145
NCIOpen2_005182
NCIOpen2_005185
NCIOpen2_005187
NCIOpen2_005200
NCIOpen2_005575
NCIOpen2_005980
NCIOpen2_009422
NINDS_000038
NSC 474
NSC474
P0446
P0447
P45907_SIAL
PIPERAZINE (HEXAHYDRATE)
PZE
Piperazidine
Piperazin
Piperazin [German]
Piperazin [Germany]
Piperazine (USP)
Piperazine Dihydrochloride Dihydrochloride Hydrate
Piperazine Hexa-Hydrate
Piperazine [UN2579] [Corrosive]
Piperazine [UN2579] [Corrosive]
Piperazine [USAN]
Piperazine anhydrous
Piperazine hexahydrate
Piperazine hydrate
Piperazine, anhydrous
Pipersol
Pyrazine hexahydride
Pyrazine, hexahy
SPECTRUM1500490
Spectrum5_001817
Spectrum_001113
UN2579
UNII-1RTM4PAL0V
Upixon
Uvilon
Vermex
Vermizine
Vermizine (TN)
WLN: T6M DMTJ
Worm-A-Ton
Worm-away
Wurmirazin
nchembio814-comp12
piperazine
piperazinium oleate
11
Diethylcarbamazineapproved, vet_approved1490-89-13052
Synonyms:
1-Diethylcarbamyl-4-methylpiperazine
12672-34-3
1642-54-2 (citrate (1:1))
4-23-00-00225 (Beilstein Handbook Reference)
5348-97-0
5348-97-0 (mono-hydrochloride)
8028-18-0
84L
90-89-1
AB00053457
AC1L1F2E
AI3-19612
AKOS003268016
BPBio1_000208
BRD-K45542189-048-05-6
BRN 0143029
BSPBio_000188
BSPBio_002179
Bitirazine
C07968
CHEMBL684
CID3052
Camin
Camin (TN)
Caracide
Carbamazine
Carbilazine
Caricide
Cypip
D07825
DB00711
Decacide
Diaethylcarbamazinum
Diethyl carbamazine
Diethylcarbamazin
Diethylcarbamazine (INN)
Diethylcarbamazine [INN:BAN]
Diethylcarbamazinum
Diethylcarbamazinum [INN-Latin]
 
Dietilcarbamazina
Dietilcarbamazina [INN-Spanish]
Ditrazine Base
Ditrazine base
DivK1c_000548
Diéthylcarbamazine
EINECS 202-023-3
Ethodryl
FR-1031
IDI1_000548
KBio1_000548
KBio2_001418
KBio2_003986
KBio2_006554
KBio3_001399
KBioGR_001081
KBioSS_001418
LS-110688
Luxuran
MolPort-001-788-448
N,N-Diethyl-4-methyl-1-piperazinecarboxamide
N,N-diethyl-4-methylpiperazine-1-carboxamide
NCGC00178778-01
NCGC00178778-02
NINDS_000548
NSC1364
Notezine
Prestwick0_000284
Prestwick1_000284
Prestwick2_000284
Prestwick3_000284
SPBio_001203
SPBio_002407
Spatonin
Spectrum2_001022
Spectrum3_000390
Spectrum4_000511
Spectrum5_000877
Spectrum_000938
UNII-V867Q8X3ZD
diethylcarbamazine
12Ether60
13Disinfectants547
14Piperazine citrate24

Interventional clinical trials:

idNameStatusNCT IDPhase
1Ivermectin Versus Albendazole for Chronic StrongyloidiasisUnknown statusNCT00765024Phase 3
2Multiple Versus Single Dose of Ivermectin for the Treatment of StrongyloidiasisRecruitingNCT01570504Phase 3
3Management of Soil-transmitted Helminthiasis and StrongyloidiasisUnknown statusNCT01308268
4Study of Patients With Strongyloides Stercoralis InfectionCompletedNCT00001245
5Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm InfectionsCompletedNCT00207753
6The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon IslandsCompletedNCT01080989
7Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive DisordersCompletedNCT02105714
8Host Response to Infection and Treatment in Lymphatic Filarial Disease in IndiaRecruitingNCT00342576
9Parasitic Infections of the Gastrointestinal TractRecruitingNCT00001162

Search NIH Clinical Center for Strongyloidiasis

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: strongyloidiasis

Genetic Tests for Strongyloidiasis

About this section

Anatomical Context for Strongyloidiasis

About this section

MalaCards organs/tissues related to Strongyloidiasis:

36
Skin, Testes, Lung, T cells, Kidney, Colon, Liver

Publications for Strongyloidiasis

About this section

Articles related to Strongyloidiasis:

(show top 50)    (show all 586)
idTitleAuthorsYear
1
Strongyloidiasis-Related IRIS. (27733639)
2017
2
Application of real-time PCR for the diagnosis of strongyloidiasis in North Queensland. (27773069)
2016
3
Strongyloidiasis: A Disease of Socioeconomic Disadvantage. (27213420)
2016
4
Acute strongyloidiasis in a traveller returning from South East Asia. (27192701)
2016
5
Donor-Derived Strongyloidiasis Infection in Solid Organ Transplant Recipients: A Review and Pooled Analysis. (27742318)
2016
6
Incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers. (27432907)
2016
7
Effect of ivermectin on allergy-type manifestations in occult strongyloidiasis. (27566864)
2016
8
Chronic strongyloidiasis - Don't look and you won't find. (27051986)
2016
9
Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States. (26925367)
2016
10
Strong-LAMP: A LAMP Assay for Strongyloides spp. Detection in Stool and Urine Samples. Towards the Diagnosis of Human Strongyloidiasis Starting from a Rodent Model. (27415764)
2016
11
Gastric Strongyloidiasis: Report of 2 Cases and Brief Review of the Literature. (27965275)
2016
12
Linear and urticarial rash-like manifestation of acute strongyloidiasis. (27613704)
2016
13
Potential immunological markers for diagnosis of human strongyloidiasis using heterologous antigens. (27894367)
2016
14
Comparative Diagnosis of Strongyloidiasis in Immunocompromised Patients. (27296387)
2016
15
Strongyloidiasis in Ontario: Performance of diagnostic tests over a 14-month period. (27794473)
2016
16
Pulmonary Strongyloidiasis Masquerading as Exacerbation of Chronic Obstructive Pulmonary Disease. (27790284)
2016
17
Poorly controlled asthma and strongyloidiasis in a nonendemic area of the United States. (27298264)
2016
18
Protein Loosing Enteropathy Secondary to Strongyloidiasis: Case Report and Review of the Literature. (26881152)
2016
19
Advocating for both Environmental and Clinical Approaches to Control Human Strongyloidiasis. (27706031)
2016
20
StrongNet: An International Network to Improve Diagnostics and Access to Treatment for Strongyloidiasis Control. (27607192)
2016
21
Epidemiological Characteristics of Strongyloidiasis in Inhabitants of Indigenous Communities in Borneo Island, Malaysia. (27853126)
2016
22
Strongyloides stercoralis diagnostic polypeptides for human strongyloidiasis and their proteomic analysis. (27312043)
2016
23
Severe strongyloidiasis in AIDS: relative risk obscured by absolute rarity. (26825034)
2016
24
Seroprevalence of fascioliasis, toxocariasis, strongyloidiasis and cysticercosis in blood samples diagnosed in Medic Medical Center Laboratory, Ho Chi Minh City, Vietnam in 2012. (27595647)
2016
25
Short epitope-based synthetic peptides for serodiagnosis of human strongyloidiasis. (26956434)
2016
26
Notes from the Field: Strongyloidiasis at a Long-Term-Care Facility for the Developmentally Disabled - Arizona, 2015. (27310213)
2016
27
Pulmonary strongyloidiasis and hyperinfection in a renal transplant patient. (27891008)
2016
28
Strongyloidiasis Presenting as Epigastric Pain. (27924100)
2016
29
Strongyloidiasis in the immunocompetent: an overlooked infection. (27609726)
2016
30
A case of disseminated strongyloidiasis in adelaide diagnosed on peritoneal biopsy. (27773170)
2016
31
Strongyloidiasis in a young French woman raises concern about possible ongoing autochthonous transmission in Spain. (26617257)
2016
32
Strongyloidiasis in Latin American immigrants: a pilot study. (27121364)
2016
33
Megaduodenum associated with gastric strongyloidiasis. (25951613)
2015
34
Disseminated strongyloidiasis in a patient with membranoproliferative glomerulonephritis-case report. (25904959)
2015
35
Strongyloidiasis: A case with acute pancreatitis and a literature review. (25805946)
2015
36
Persistent Strongyloidiasis Complicated by Recurrent Meningitis in an HTLV Seropositive Peruvian Migrant Resettled in Italy. (25846292)
2015
37
Gastrointestinal strongyloidiasis. (26062140)
2015
38
Strongyloides stercoralis infection in patients with systemic lupus erythematosus: diagnosis and prevention of severe strongyloidiasis. (26258603)
2015
39
Disseminated gastrointestinal strongyloidiasis. (26481977)
2015
40
Strongyloidiasis: an unusual cause of septic shock with pneumonia and enteropathy in western countries. (25819827)
2015
41
Immunofluorescence assay for diagnosis of strongyloidiasis in immunocompromised patients. (25832456)
2015
42
Strongyloidiasis in immigrants and refugees in Canada. (26149698)
2015
43
Strongyloidiasis: a case for notification in Australia? (26021359)
2015
44
Is strongyloidiasis endemic in Spain? (25654324)
2015
45
Five cases of recurrent meningitis associated with chronic strongyloidiasis. (25548379)
2015
46
Comparative evaluation of Strongyloides ratti and S. stercoralis larval antigen for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis. (25877389)
2015
47
Molecular diagnosis of strongyloidiasis in tropical areas: a comparison of conventional and real-time polymerase chain reaction with parasitological methods. (25946255)
2015
48
Strongyloidiasis with emphasis on human infections and its different clinical forms. (25911368)
2015
49
IMMUNODIAGNOSIS OF HUMAN STRONGYLOIDIASIS: USE OF SIX DIFFERENT ANTIGENIC FRACTIONS FROM Strongyloides venezuelensis PARASITIC FEMALES. (26603231)
2015
50
Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy. (25925183)
2015

Variations for Strongyloidiasis

About this section

Expression for genes affiliated with Strongyloidiasis

About this section
Search GEO for disease gene expression data for Strongyloidiasis.

Pathways for genes affiliated with Strongyloidiasis

About this section

Pathways related to Strongyloidiasis according to GeneCards Suite gene sharing:

(show all 18)
idSuper pathwaysScoreTop Affiliating Genes
19.7IFNG, IL5
29.6IFNG, TGFB1
3
Show member pathways
9.6IFNG, TGFB1
49.6IFNG, TGFB1
59.3CD79A, IFNG, IL5
6
Show member pathways
9.1IFNG, IL13, IL5
79.1IFNG, IL13, IL5
89.1IFNG, IL13, IL5
99.1IFNG, IL13, IL5
109.1IL13, IL5, TGFB1
119.0IFNG, IL13, TGFB1
129.0CCL11, IL13, IL5
13
Show member pathways
8.9CD79A, IFNG, IL5, TGFB1
148.6IFNG, IL13, IL5, TGFB1
158.6CCL11, IFNG, IL13, IL5
16
Show member pathways
8.1CCL11, IFNG, IL13, IL5, TGFB1
17
Show member pathways
8.1CCL11, IFNG, IL13, IL5, TGFB1
18
Show member pathways
8.1CCL11, IFNG, IL13, IL5, TGFB1

GO Terms for genes affiliated with Strongyloidiasis

About this section

Cellular components related to Strongyloidiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.8CD79A, IFNG, IL13
2extracellular regionGO:00055768.8CCL11, IFNG, IL13, IL5, TGFB1
3extracellular spaceGO:00056158.1CCL11, IFNG, IL13, IL5, TGFB1

Biological processes related to Strongyloidiasis according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1extrinsic apoptotic signaling pathwayGO:009719110.3IFNG, TGFB1
2negative regulation of interleukin-17 productionGO:003270010.2IFNG, TGFB1
3positive regulation of B cell proliferationGO:003089010.0IL13, IL5
4protein import into nucleus, translocationGO:000006010.0IFNG, TGFB1
5positive regulation of protein secretionGO:00507149.9IL13, TGFB1
6response to radiationGO:00093149.5CCL11, TGFB1
7inflammatory responseGO:00069549.1CCL11, IL13, IL5, TGFB1

Molecular functions related to Strongyloidiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051258.6IFNG, IL13, IL5, TGFB1

Sources for Strongyloidiasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet